| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 4 |
| estrogen nuclear receptor alpha | 7 | 0 | 0 | 7 |
| Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
| Free fatty acid receptor 2 | 0 | 1 | 1 | 2 |
| Tyrosine-protein kinase Lck | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 0 | 1 | 1 |
| Fibrinogen C domain-containing protein 1 | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
| Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| AR protein | 8 | 0 | 0 | 8 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 4 | 0 | 1 | 0 | 2 |
| Bile salt export pump | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 3 | 0 | 3 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
| RAR-related orphan receptor gamma | 5 | 0 | 0 | 5 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 1, group I, member 3 | 6 | 0 | 0 | 6 |
| retinoic acid nuclear receptor alpha variant 1 | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 4 | 0 | 0 | 4 |
| Cellular tumor antigen p53 | 5 | 0 | 0 | 5 |
| Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
| TDP1 protein | 4 | 0 | 0 | 4 |
| GLI family zinc finger 3 | 5 | 0 | 0 | 5 |
| progesterone receptor | 4 | 0 | 0 | 4 |
| glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
| retinoid X nuclear receptor alpha | 5 | 0 | 0 | 5 |
| estrogen-related nuclear receptor alpha | 6 | 0 | 0 | 6 |
| peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform 2 | 4 | 0 | 0 | 4 |
| Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
| Glutamate receptor 2 | 3 | 0 | 0 | 3 |
| ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
| Ataxin-2 | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
| Insulin-degrading enzyme | 0 | 1 | 0 | 1 |
| Luciferase | 3 | 0 | 0 | 3 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
| peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
| Histone H2A.x | 3 | 0 | 0 | 3 |
| geminin | 4 | 0 | 0 | 4 |
| lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
| acetylcholinesterase | 1 | 0 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
| aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
| activating transcription factor 6 | 2 | 0 | 0 | 2 |
| B2 bradykinin receptor | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 0 | 1 |
| Beta-galactosidase | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 0 | 2 | 0 | 2 |
| PH domain leucine-rich repeat-containing protein phosphatase 2 | 0 | 1 | 0 | 1 |
| Chymotrypsin-C | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 2 | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 0 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Thromboxane A2 receptor | 0 | 1 | 1 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 3 | 2 | 5 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 3 | 1 | 4 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 2 | 4 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 3 | 2 | 5 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 3 | 1 | 4 |
| Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
| Prostacyclin receptor | 0 | 3 | 1 | 4 |
| Prostaglandin D2 receptor | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 3 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| SMAD family member 2 | 2 | 0 | 0 | 2 |
| SMAD family member 3 | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
| farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
| prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 0 | 1 | 1 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
| phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| RAR-related orphan receptor alpha | 1 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
| hormone receptor 3, isoform A | 1 | 0 | 0 | 1 |
| Spike glycoprotein | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| ATAD5 protein, partial | 1 | 0 | 0 | 1 |
| ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
| Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Platelet-activating factor receptor | 1 | 0 | 0 | 1 |
| Histamine H2 receptor | 1 | 0 | 0 | 1 |
| Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
| Non-structural protein 1 | 0 | 1 | 0 | 1 |
| pregnane X nuclear receptor | 1 | 0 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |